Study to evaluate the safety and tolerability of KIT2014, an inhaled peptide therapy designed to enhance Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) function, act as a bronchodilator, ...

management include treatment of symptoms and prevention of exacerbations. Current guidelines recommend use of one or more long-acting inhaled bronchodilators for patients with moderate ...

TURIN, Italy I October 30, 2024 I Kither Biotech, a clinical-stage biotech company focused on innovative therapies for respiratory diseases, today announced ...

Gangdong Kyunghee University Hospital (Director Lee Woo-in) won the first grade in the 9th COPD adequacy evaluation announced ...

A NEW multicenter study, TOReTO, has shown that dual bronchodilator therapy can help reduce exacerbations in patients with chronic obstructive pulmonary disease (COPD), with notable differences in ...

Frequency of requirements for intervention measures, inhaled bronchodilators and oral corticosteroids. Treatment of Asthma Intervention measures for relief of acute symptoms, albuterol and oral ...

Opens in a new tab or window BOSTON -- Inhaled corticosteroids ... for asthma treatment were associated with reduced risks of severe exacerbations compared with bronchodilator-only relievers ...

A study published in JAMA reports on data showing that Combination ICS-SABA and ICS-Formoterol asthma treatments are more ...

Do cough, cold or other respiratory issues disrupt your sleep in the rising air pollution? Explore the best nebulizer ...

These preclinical findings could lead ... Single-Dose Gene Therapy Is Potentially Life-Changing for Adults With Hemophilia B Sep. 25, 2024 — Adults with hemophilia B saw their number of bleeding ...